Search Within

Department of Medicine

Formats
  1. Journal Article (19605)
  2. Meeting Abstract (16046)
  3. Review (1157)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (315)
  7. Conference Paper (301)
  8. Guidelines (297)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22336)
  2. Hematologic Malignancies, Division of (13285)
  3. Center for Hematologic Malignancies (11068)
  4. GSK Faculty (10649)
  5. Survivorship Research (9339)
  6. Division of Subspecialty Medicine (7547)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1101)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2288)
  6. Nature Publishing Group (2118)

More Publishers

Results (39652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 17-Allylamino-geldanamycin causes AKT inactivation and enhances the anti-tumor effects of paclitaxel
    Meeting Abstract

    Solit, D. B.; Basso, A. D.; Munster, P. N.; Norton, L.; Scher, H. I.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces differentiation of human breast cancer cells
    Meeting Abstract

    Munster, P. N.; Rosen, N.; Rifkind, R.; Marks, P.; Richon, V.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase I trial of 17AAG (17-allylamino) 17-demethoxygeldanamycin (17AAG) in patients (Pts) with advanced cancer
    Meeting Abstract

    Scher, H. I.; Solit, D. B.; Munster, P. N.; Tong, W. P.; Lawrence, S.; Kenneson, K.; Larson, S.; De La Cruz, A.; Reuter, V.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • A phase I/pharmacologic study of UCN-01 in combination with 5-fluorouracil in patients with advanced solid tumors
    Meeting Abstract

    Shah, M. A.; Kortmansky, J.; Kelsen, D. P.; Hseuh, C.; Kaubisch, A.; Spriggs, D.; Gonen, M.; Tong, W.; Endres, S.; Schwartz, G. K.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Decreasing risk of complications of colonoscopic polypectomy over the 10-year National Polyp Study
    Meeting Abstract

    Carlson, M. D. A.; Zauber, A. G.; Schnoll-Sussman, F.; Waye, J.; Bond, J.; Schapiro, M.; Winawer, S. J.
    Cancer Epidemiology Biomarkers and Prevention (2001)

    Fulltext@MSK | Save
  • Effect of cardiac dysfunction on treatment outcome in the Herceptin (trastuzumab) pivotal trial
    Meeting Abstract

    Tripathy, D.; Seidman, A.; Hudis, C.; Pierri, M. K.; Keefe, D.
    Breast Cancer Research and Treatment (2001)

    Fulltext@MSK | Save
  • Role of epoetin alpha in maintaining hemoglobin and quality of life in breast cancer patients receiving adjuvant chemotherapy or chemoradiation
    Meeting Abstract

    Hudis, C. A.; Williams, D.; Gralow, J. R.
    Breast Cancer Research and Treatment (2001)

    Fulltext@MSK | Save
  • Results of a randomized study of Bexxar (TM) (tositumomab and iodine I 131 tositumomab) vs. unlabeled tositumomab in patients with relapsed or refractory low-grade or transformed non-Hodgkin's lymphoma (NHL)
    Meeting Abstract

    Davis, T. A.; Kaminski, M. S.; Leonard, J. P.; Gregory, S. A.; Wahl, R.; Hsu, F. J.; Wilkinson, M.; Frankel, S. R.; Serafini, A.; Zelenetz, A. D.; more...
    Blood (2001)

    Fulltext@MSK | Save
  • Mutations of the PML tumor suppressor gene in RA-resistant APL
    Meeting Abstract

    Gurrieri, C.; Nafa, K.; Merghoub, T.; Jain, V.; Douer, D.; Biondi, A.; Nimer, S.; Gallagher, R.; Pandolfi, P. P.
    Blood (2001)

    Fulltext@MSK | Save
  • A knock-in mouse model for the analysis of the role of PLZF-RAR alpha in leukemogenesis
    Meeting Abstract

    Costoya, J. A.; Merghoub, T.; Pandolfi, P. P.
    Blood (2001)

    Fulltext@MSK | Save